Repros (RPRX) Updates on Oral Proellex; Says FDA May Upgrade on New Phase 2 Protocol
Go back to Repros (RPRX) Updates on Oral Proellex; Says FDA May Upgrade on New Phase 2 Protocol| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 61.25 -0.48 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.73 | 52 Week High | $3.48 | |||
| Open | $61.33 | 52 Week Low | $0.80 | |||
| Day High | $62.13 | P/E | N/A | |||
| Day Low | $60.80 | EPS | $-1.54 | |||
| Volume | 1,059,502 | |||||
